Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overview of current and emerging therapies for amytrophic lateral sclerosis
Jeff Prescott, Angelia Szwed, Danielle Jamison, et al.
The American Journal of Managed Care (2020) Vol. 26, Iss. Suppl 9, pp. S191-S197
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Gene therapy for ALS: A review
Defne A. Amado, Beverly L. Davidson
Molecular Therapy (2021) Vol. 29, Iss. 12, pp. 3345-3358
Open Access | Times Cited: 135
Tipping the balance: intricate roles of the complement system in disease and therapy
Richard B. Pouw, Daniel Ricklin
Seminars in Immunopathology (2021) Vol. 43, Iss. 6, pp. 757-771
Open Access | Times Cited: 115
Tofersen: First Approval
Hannah A. Blair
Drugs (2023) Vol. 83, Iss. 11, pp. 1039-1043
Closed Access | Times Cited: 89
Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis
Sagar Verma, Shiffali Khurana, Kavita Vats, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1502-1527
Closed Access | Times Cited: 71
Fluid biomarkers for amyotrophic lateral sclerosis: a review
Katherine E. Irwin, Udit Sheth, Philip C. Wong, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 28
A randomized placebo‐controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis
Merit Cudkowicz, Stacy Lindborg, Namita Goyal, et al.
Muscle & Nerve (2021) Vol. 65, Iss. 3, pp. 291-302
Open Access | Times Cited: 71
Oligodendrocyte Dysfunction in Amyotrophic Lateral Sclerosis: Mechanisms and Therapeutic Perspectives
Stefano Raffaele, Marta Boccazzi, Marta Fumagalli
Cells (2021) Vol. 10, Iss. 3, pp. 565-565
Open Access | Times Cited: 61
Gene Therapy in ALS and SMA: Advances, Challenges and Perspectives
Jan Lejman, Kinga Panuciak, Emilia Nowicka, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1130-1130
Open Access | Times Cited: 22
The panoramic view of amyotrophic lateral sclerosis: A fatal intricate neurological disorder
Swati Dhasmana, Anupam Dhasmana, Acharan S. Narula, et al.
Life Sciences (2021) Vol. 288, pp. 120156-120156
Closed Access | Times Cited: 38
Current potential therapeutics of amyotrophic lateral sclerosis
Lijun Lu, Youqing Deng, Renshi Xu
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 5
Inosine in Neurodegenerative Diseases: From the Bench to the Bedside
Maria Sofia Basile, Placido Bramanti, Emanuela Mazzon
Molecules (2022) Vol. 27, Iss. 14, pp. 4644-4644
Open Access | Times Cited: 22
CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics
Tirthankar Sen, Rajkumar P. Thummer
Neurotoxicity Research (2022) Vol. 40, Iss. 5, pp. 1597-1623
Open Access | Times Cited: 21
TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: From pathomechanisms to therapeutic strategies
Pei‐Chuan Ho, Tsung‐Chi Hsieh, Kuen‐Jer Tsai
Ageing Research Reviews (2024) Vol. 100, pp. 102441-102441
Open Access | Times Cited: 4
A Review of Biomarkers of Amyotrophic Lateral Sclerosis: A Pathophysiologic Approach
Rawiah S. Alshehri, Ahmad R. Abuzinadah, Moafaq S. Alrawaili, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 10900-10900
Open Access | Times Cited: 4
Enhancing ALS disease management: exploring integrated user value through online communities evidence
Jan Hruška, Pavel Bachmann, Samuel Amponsah Odei
Frontiers in Neurology (2025) Vol. 15
Open Access
Neuroscience20 (BRAIN20, SPINE20, and MENTAL20) Health Initiative: A Global Consortium Addressing the Human and Economic Burden of Brain, Spine, and Mental Disorders Through Neurotech Innovations and Policies
Kevin Morris, Mohammad Nami, Joe F. Bolanos, et al.
Journal of Alzheimer s Disease (2021) Vol. 83, Iss. 4, pp. 1563-1601
Closed Access | Times Cited: 16
Ebselen analogues delay disease onset and its course in fALS by on-target SOD-1 engagement
Seiji Watanabe, Kangsa Amporndanai, Raheela Awais, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Proteomic analysis of cerebrospinal fluid of amyotrophic lateral sclerosis patients in the presence of autologous bone marrow derived mesenchymal stem cells
Ana Luiza Guimarães Reis, Jéssica Ruivo Maximino, Luís Alberto de Pádua Covas Lage, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Safety and Efficacy of Edaravone in Patients with Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-analysis
Mengxia Gao, Lingqun Zhu, Jingling Chang, et al.
Clinical Drug Investigation (2022) Vol. 43, Iss. 1, pp. 1-11
Closed Access | Times Cited: 10
Promoting regeneration while blocking cell death preserves motor neuron function in a model of ALS
Josette J Wlaschin, Caroline Donahue, Jacob M Gluski, et al.
Brain (2022) Vol. 146, Iss. 5, pp. 2016-2028
Open Access | Times Cited: 8
MATR3 P154S knock-in mice do not exhibit motor, muscle or neuropathologic features of ALS
Marissa Dominick, Nicole Houchins, Vinisha Venugopal, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 645, pp. 164-172
Open Access | Times Cited: 4
Development of novel treatments for amyotrophic lateral sclerosis
Zhuo Sun, Bo Zhang, Ying Peng
Metabolic Brain Disease (2023) Vol. 39, Iss. 3, pp. 467-482
Closed Access | Times Cited: 4
Glycolic acid and D-lactate—putative products of DJ-1—restore neurodegeneration in FUS - and SOD1-ALS
Arun Pal, Dajana Großmann, Hannes Glaß, et al.
Life Science Alliance (2024) Vol. 7, Iss. 8, pp. e202302535-e202302535
Open Access | Times Cited: 1
Differential Expression of MicroRNAs and Predicted Drug Target in Amyotrophic Lateral Sclerosis
Riya Ben Patel, Akhilesh Kumar Bajpai, Kavitha Thirumurugan
Journal of Molecular Neuroscience (2023) Vol. 73, Iss. 6, pp. 375-390
Closed Access | Times Cited: 3
Kaempferol and kaempferide against amyotrophic lateral sclerosis
E. Srinivasan, G. Chandrasekhar, R. Rajasekaran
Elsevier eBooks (2023), pp. 163-178
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top